Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 41 - 50 of 72 opportunities
This technology developed at the University of Aberdeen relates to the discovery of mutation of a single gene in individuals with classical autism. The gene is involved in protein translation and offers possibilities in the diagnostic and therapeutic markets for those with autism spectrum disorder.
Aberdeen researchers have developed a novel antibody that demonstrates clear activity against C. albicans in vitro in an immune system-independent manner.
Catanostics (Cataract Diagnostics) offers an alternative to the slit lamp currently used for cataract diagnosis before referring a patient for cataract surgery.
Our non-invasive fluorescence scan offers "better diagnosis" through non-subjective analysis of data on cataract symptoms & severity lea...
Drug-eluting stents (DES) have significantly reduced rates of restenosis compared to their bare metal counterparts and are now increasingly the treatment of choice for percutaneous coronary revascularisations. Despite this, they are not suitable for all cases and anti-platelet therapy can still be r...
Natural products are perceived to be too difficult to use in the ultra-high throughput screening approach preferred by pharmaceutical companies. We have developed a method which allows high throughput screening of anticancer agents directly on cells from samples of ovarian tumours from patients...
The innovation provides a gas-induced method for phase-transforming organic solids, such as pharmaceutical crystals. The inventive method subjects the polymorphs of pharmaceutical agents to various pressures of gases (such as CO2, N2O, and CH4) to induce phase transform with ease.
This new bioinformatic method increases gene expression by at least 10-fold to improve protein production yield leading to cheaper and faster RNA virus vaccine production. This could provide a valuable edge in producing vaccines against a seasonal or pandemic virus.
Heriot-Watt International Centre for Brewing and Distilling has developed a proprietary method to treat certain types of Beer to significantly reduce the level of Gluten protein present (demonstrated to
Edinburgh Super Resolution Imaging (ESRIC)is a collaboration between Edinburgh and Heriot-Watt Universities offering access to unique bio photonics imaging facilities for cellular studies to investigate cellular function and human disease processes.
ESRIC seeks research and commercial partners a...
Water content in Oil & Gas transfer pipes is critical to Hydrocarbon processing and transfer.
Having proven the concept, HWU is developing technology to meet this need and seeks Industry partners for licensing & co-development of a new range of solid state sensors for Oil or Gas pipelines.